Tirzepatide Clinical Evidence and Injection Cost Analysis
Tirzepatide injection cost is a key consideration for patients and prescribers given its FDA-approved use for diabetes and weight management. Oral tirzepatide formulations remain investigational and unavailable for clinical use. This article reviews…
GLP-1 Semaglutide Dosage Chart: Clinical Guide
This semaglutide dosing guide provides a clinical chart and protocol for effective use in diabetes and weight management. It highlights distinct titration schedules for Ozempic and Wegovy. Understanding dosing is essential for safety and efficacy in…
GLP-1 Medications May Quiet the Craving Behind Addiction
A landmark BMJ study published June 3, 2026 found that GLP-1 receptor agonists like semaglutide significantly reduced both the development and severity of substance use disorders in over 600,000 U.S. veterans. Cannabis use disorder risk dropped 14%,…
What a Large 2026 Study Reveals About GLP-1 Medications and Hair Loss
Semaglutide hair loss risk emerged as a significant signal in a large propensity-matched cohort study involving hundreds of thousands of patients. Researchers found higher rates of nonscarring hair loss among semaglutide and tirzepatide users compared…
GLP-1 Drugs, Semaglutide, and the Future of Alcohol Addiction Treatment
GLP-1 receptor agonists for alcohol use disorder are attracting growing scientific interest as potential tools for reducing alcohol consumption and relapse risk. This review examines preclinical evidence, observational studies, and randomized controlled…
Weight Loss Outcomes Between GLP-1 Receptor Agonists and Bariatric Surgery in Adults
GLP-1 bariatric surgery meta-analysis evidence suggests bariatric surgery produced greater long-term weight and BMI reduction in the reviewed studies. The comparison also found stronger longer-term glycemic outcomes for surgery, while lipid and blood…
Weight Loss, Metabolic Health, and Psychiatric Safety
Semaglutide for schizophrenia weight gain is emerging as a focused metabolic strategy for patients whose antipsychotic treatment has created serious weight and glucose burden. This Evidence Watch review examines RCT meta-analysis data showing meaningful…
Use of Oral Semaglutide and Associated Clinical Outcomes in Thai Patients With Diabetes
The REALISED study shows significant improvements in HbA1c and body weight among Thai patients using oral semaglutide. No severe hypoglycaemia was reported.
Superior Cerebrovascular Outcomes with Tirzepatide versus Semaglutide in Diabetic Patients
A study comparing Tirzepatide to Semaglutide in diabetic CABG patients found significant benefits for cerebrovascular and cardiovascular outcomes, reducing mortality and complications.
Systematic Characterisation of GLP-1R in Human Enteric Nervous System- Implicati
GLP-1R is abundantly expressed in the colonic enteric nervous system, preferentially in inhibitory neurons. This study provides insights into GLP-1 receptor agonist-induced gastrointestinal dysmotility.